NASDAQ:MDRX Veradigm (MDRX) Stock Price, News & Analysis $4.75 -0.23 (-4.52%) As of 09:30 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsFinancialsNews and TrendsSEC Filings About Veradigm Stock (NASDAQ:MDRX) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Veradigm alerts:Sign Up Key Stats Today's Range$4.75▼$4.7550-Day Range$4.55▼$5.1452-Week Range$3.25▼$5.60Volume227 shsAverage Volume117,072 shsMarket Capitalization$580.93 millionP/E Ratio23.25Dividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Veradigm is a healthcare technology company that develops software and data solutions for medical practices, health systems, payers and life sciences organizations. Its offerings include electronic health record and practice-management tools, revenue-cycle services, and technology for coordinating care and managing clinical and administrative workflows. The company also provides data and analytics products that help healthcare organizations and life sciences companies support research, understand patient populations and inform decisions. Its operations primarily serve customers in the United States. Veradigm was formerly known as Allscripts Healthcare Solutions and adopted the Veradigm name in 2023, following the sale of its hospital and large-health-system business. The company focuses on outpatient healthcare technology and data-driven services.AI Generated. May Contain Errors. Read More Receive MDRX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Veradigm and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. MDRX Stock News HeadlinesVeradigm (NASDAQ:MDRX) Stock Crosses Above 200 Day Moving Average - What's Next?November 13 at 3:45 AM | americanbankingnews.comVeradigm Reports Delay in Third-Quarter FilingNovember 10 at 6:11 PM | tipranks.comWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indicator for a single $7 payment. Others previously paid $500. The indicator flashes a Crash Alert as a cue to exit or go short, and a Bull Run Alert as a cue to buy or go long. No strings attached, and Wood says there is an unusual reason behind the steep discount.November 13 at 1:00 AM | Base Camp Trading (Ad)Veradigm (NASDAQ:MDRX) Stock Price Crosses Below Two Hundred Day Moving Average - Here's What HappenedNovember 4, 2026 | americanbankingnews.comVeradigm Product Portfolio Achieves HITRUST i1 CertificationOctober 21, 2026 | finance.yahoo.comVeradigm reports limited patient data cybersecurity breachSeptember 10, 2026 | theglobeandmail.comVeradigm Announces Updated Presentation Time for Upcoming Investor ConferenceSeptember 8, 2026 | finance.yahoo.comVeradigm to Participate in Two Upcoming Investor ConferencesAugust 17, 2026 | businesswire.comSee More Headlines MDRX Stock Analysis - Frequently Asked Questions How have MDRX shares performed this year? Veradigm's stock was trading at $4.60 at the start of the year. Since then, MDRX shares have increased by 3.3% and is now trading at $4.75. How were Veradigm's earnings last quarter? Veradigm Inc. (NASDAQ:MDRX) released its quarterly earnings data on Thursday, November, 4th. The software maker reported $0.27 EPS for the quarter, beating the consensus estimate of $0.18 by $0.09. Veradigm's quarterly revenue was down 8.2% on a year-over-year basis. Does Veradigm have any subsidiaries? The following companies are subsidiaries of Veradigm: ZappRx, HealthGrid, and Practice Fusion. How do I buy shares of Veradigm? Shares of MDRX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Veradigm own? Based on aggregate information from My MarketBeat watchlists, some other companies that Veradigm investors own include AT&T (T), Netflix (NFLX), Hewlett Packard Enterprise (HPE), Advanced Micro Devices (AMD), Costco Wholesale (COST), FuelCell Energy (FCEL) and Gilead Sciences (GILD). Company Calendar Today11/13/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Technology Sub-IndustryHealthcare Technology Current SymbolNASDAQ:MDRX CIK1124804 Webveradigm.com Phone(800) 334-8534Fax313-322-9600Employees2,300Year Founded1986Profitability EPS (Trailing Twelve Months)N/A Trailing P/E Ratio23.25 Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$1.53 billion Price / Sales0.38 Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares122,300,000Free Float105,175,000Market Cap$580.93 million OptionableNo Data Beta0.50 Social Links The 7 Best High-Yield Dividend Stocks for 2027Looking for higher dividend income in 2027? Discover seven high-yield dividend stocks with attractive payouts, proven dividend histories and growth potential.Get This Free Report This page (NASDAQ:MDRX) was last updated on 11/13/2026 by MarketBeat.com Staff. From Our PartnersWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredTrump’s EO to send this $5 stock ripping higher…?President Trump's December executive order declared space a national security and economic priority, fueling a...Traders Agency | SponsoredToday's free pick (on me)Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one l...Behind the Markets | SponsoredTrump compared today's market to 1929President Trump warned of a 1929-style depression if Democrats won control of Congress. On November 3, they di...USA Capital Gold | SponsoredYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | SponsoredURGENT: If you own a home, please review the map below.More than 1,300 red dots are scattered across the country, and 2,800 more are already on the way. Jim Rickards...Paradigm Press | SponsoredUranium Mine Flood That Sparked a 2006 Price Surge ReturnsIn 2006, a flooded mine at Cigar Lake sent uranium prices from the $50 range to $136 in eight months. This pa...Digest Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Veradigm Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Veradigm With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MDRX Stock Alerts